Plasma pro-brain natriuretic peptides are strong biochemical markers in clinical cardiology
- 1 January 2001
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 61 (234) , 47-51
- https://doi.org/10.1080/clb.61.234.47.51
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The role of C-type natriuretic peptide in cardiovascular medicineEuropean Heart Journal, 2001
- Plasma amino-terminal pro-brain natriuretic peptide: A novel approach to the diagnosis of cardiac dysfunctionJournal of Cardiac Failure, 2000
- Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay methodScandinavian Journal of Clinical and Laboratory Investigation, 2000
- Development of a novel, N-Terminal-proBNP (NT-proBNP) assay with a low detection limitScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- Plasma brain natriuretic peptide in assessment of acute dyspnoeaThe Lancet, 1994
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)Biochemical and Biophysical Research Communications, 1984
- SPECIFIC GRANULES IN ATRIAL MUSCLE CELLSThe Journal of cell biology, 1964